• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌首次复发病变模式:肝转移与预后不良及门静脉侵犯相关。

Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion.

作者信息

Suenaga Masaya, Fujii Tsutomu, Kanda Mitsuro, Takami Hideki, Okumura Norio, Inokawa Yoshikuni, Kobayashi Daisuke, Tanaka Chie, Yamada Suguru, Sugimoto Hiroyuki, Nomoto Shuji, Fujiwara Michitaka, Kodera Yasuhiro

出版信息

Hepatogastroenterology. 2014 Sep;61(134):1756-61.

PMID:25436375
Abstract

BACKGROUND/AIMS: The aim of this study was to evaluate patterns of the initial recurrence after pancreatectomy for pancreatic cancer and risk factors in each pattern.

METHODOLOGY

This study included 209 pancreatic cancer patients who underwent pancreatectomy and of whom the detailed information on the first recurrent lesions detected by imaging during postoperative followup were available. Relapse patterns were classified into 4 groups: liver, peritoneal, local and extra-abdominal recurrences. We evaluated their associations with prognosis and various clinicopathological factors to identify relevant risk factors.

RESULTS

Cumulative numbers of patients with liver, peritoneal, local, and extra-abdominal recurrences were 81, 70, 98 and 22, respectively, for the first recurrences. Hepatic relapse was associated with significantly shorter overall survival than other sites (p<0.001) and was an independent prognostic factor in multivariate analysis (p<0.001). Pathological portal vein invasion was the only independent risk factor for hepatic relapse (p=0.045). There was no significant correlation between the depth of invasion and prevalence of hepatic relapse.

CONCLUSIONS

Hepatic relapse was associated with a dismal prognosis and with pathological portal vein invasion. Novel therapeutic strategies are therefore required to reduce the incidence of hepatic relapse, especially in patients with portal vein invasion.

摘要

背景/目的:本研究旨在评估胰腺癌胰十二指肠切除术后的首次复发模式及每种模式下的危险因素。

方法

本研究纳入了209例行胰十二指肠切除术的胰腺癌患者,这些患者术后随访期间通过影像学检查发现了首次复发病变的详细信息。复发模式分为4组:肝转移、腹膜转移、局部复发和腹外复发。我们评估了它们与预后及各种临床病理因素的相关性,以确定相关危险因素。

结果

首次复发时,肝转移、腹膜转移、局部复发和腹外复发的累积患者数分别为81例、70例、98例和22例。肝转移患者的总生存期显著短于其他部位转移患者(p<0.001),多因素分析显示肝转移是独立的预后因素(p<0.001)。病理门静脉侵犯是肝转移的唯一独立危险因素(p=0.045)。侵犯深度与肝转移发生率之间无显著相关性。

结论

肝转移与预后不良及病理门静脉侵犯相关。因此,需要新的治疗策略来降低肝转移的发生率,尤其是门静脉侵犯患者。

相似文献

1
Pattern of first recurrent lesions in pancreatic cancer: hepatic relapse is associated with dismal prognosis and portal vein invasion.胰腺癌首次复发病变模式:肝转移与预后不良及门静脉侵犯相关。
Hepatogastroenterology. 2014 Sep;61(134):1756-61.
2
Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.胰腺癌门静脉受累对手术切除后转移模式的影响。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):730-736. doi: 10.1245/s10434-016-5515-6. Epub 2016 Aug 23.
3
Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.重新评估门静脉-肠系膜上静脉侵犯在临界可切除胰腺癌中的临床意义。
Eur J Surg Oncol. 2017 Jun;43(6):1068-1075. doi: 10.1016/j.ejso.2017.03.020. Epub 2017 Apr 8.
4
Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.胰腺神经内分泌肿瘤:影响生存因素的多变量分析
Eur J Surg Oncol. 2014 Nov;40(11):1564-71. doi: 10.1016/j.ejso.2014.06.004. Epub 2014 Jun 30.
5
Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.胰腺癌切除术后腹膜复发的预测风险因素及其预防策略。
Surg Today. 2017 Dec;47(12):1434-1442. doi: 10.1007/s00595-017-1531-9. Epub 2017 Apr 22.
6
Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.对伴有静脉侵犯的胰腺癌患者行门静脉/肠系膜上静脉切除的胰十二指肠切除术。
Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):429-35. doi: 10.1016/s1499-3872(15)60400-3.
7
Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.胰头癌胰十二指肠切除术中门静脉-肠系膜上静脉切除的临床意义。
Pancreas. 2012 Jan;41(1):102-6. doi: 10.1097/MPA.0b013e318221c595.
8
Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer.门静脉侵犯及胰十二指肠切除术中切除长度对胰头癌生存率的影响。
Hepatogastroenterology. 2013 Oct;60(127):1759-65.
9
Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.胰腺颈部癌在门静脉侵犯和淋巴结转移方面具有特定的肿瘤学特征。
Surgery. 2016 Feb;159(2):426-40. doi: 10.1016/j.surg.2015.07.001. Epub 2015 Aug 4.
10
Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.单一癌症研究所对肝胆胰疾病患者进行的肝切除及联合血管切除的胰腺切除术
Hepatogastroenterology. 2008 May-Jun;55(84):873-8.

引用本文的文献

1
Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition.羟氯喹通过抑制髓过氧化物酶减轻胰腺腺癌的转移瘤负担。
J Inflamm (Lond). 2025 Aug 12;22(1):33. doi: 10.1186/s12950-025-00456-8.
2
Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis.预测根治性手术后复发性胰腺导管腺癌患者无进展生存期的列线图:一项回顾性分析
Front Med (Lausanne). 2024 Dec 6;11:1486750. doi: 10.3389/fmed.2024.1486750. eCollection 2024.
3
Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer.
立体定向体部放疗联合转移灶寡转移治疗与单纯原发灶治疗转移性胰腺癌的疗效比较。
Radiat Oncol. 2024 Aug 19;19(1):111. doi: 10.1186/s13014-024-02493-8.
4
Comparing upfront surgery with neoadjuvant treatments in patients with resectable, borderline resectable or locally advanced pancreatic cancer: a systematic review and network meta-analysis of randomized clinical trials.比较可切除、边界可切除或局部进展期胰腺癌患者的 upfront 手术与新辅助治疗:随机临床试验的系统评价和网络荟萃分析。
Int J Surg. 2024 Jun 1;110(6):3900-3909. doi: 10.1097/JS9.0000000000001313.
5
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survival.腹腔液外泌体 ROR1 可识别腹腔播散性 PDAC,与不良预后相关。
Front Immunol. 2024 May 23;15:1253072. doi: 10.3389/fimmu.2024.1253072. eCollection 2024.
6
The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.胰腺癌胰十二指肠切除术后血管切缘侵犯对局部复发的影响。
Langenbecks Arch Surg. 2024 Apr 12;409(1):122. doi: 10.1007/s00423-024-03301-3.
7
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.预测胰腺导管腺癌切除术后的无病生存:一项全国性队列研究。
Ann Surg. 2024 Jan 1;279(1):132-137. doi: 10.1097/SLA.0000000000006004. Epub 2023 Jul 17.
8
Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.腹腔游离肿瘤 DNA 是可切除胰腺导管腺癌局部和腹膜复发的生物标志物。
Ann Surg Oncol. 2023 Oct;30(11):6652-6660. doi: 10.1245/s10434-023-13701-2. Epub 2023 Jun 11.
9
Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.CD73 在根治性手术后对胰腺导管腺癌无病生存的预后影响。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7805-7817. doi: 10.1007/s00432-023-04703-4. Epub 2023 Apr 9.
10
Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.预测根治性切除术后胰腺导管腺癌肝转移的列线图的开发与验证
Front Oncol. 2022 Nov 21;12:1040411. doi: 10.3389/fonc.2022.1040411. eCollection 2022.